100 related articles for article (PubMed ID: 3368946)
1. Effect of cyclosporine on urinary prostanoid excretion, renal blood flow, and glomerulotubular function.
Petric R; Freeman D; Wallace C; McDonald J; Stiller C; Keown P
Transplantation; 1988 May; 45(5):883-9. PubMed ID: 3368946
[TBL] [Abstract][Full Text] [Related]
2. Effects of chronic cyclosporine administration on renal blood flow and intrarenal blood flow distribution.
Youngelman DF; Kahng KU; Rosen BD; Dresner LS; Wait RB
Transplantation; 1991 Feb; 51(2):503-9. PubMed ID: 1994546
[TBL] [Abstract][Full Text] [Related]
3. Modulation of experimental cyclosporine nephrotoxicity by inhibition of thromboxane synthesis.
Petric R; Freeman D; Wallace C; McDonald J; Stiller C; Keown P
Transplantation; 1990 Oct; 50(4):558-63. PubMed ID: 2219273
[TBL] [Abstract][Full Text] [Related]
4. Evidence that renal prostaglandin and thromboxane production is stimulated in chronic cyclosporine nephrotoxicity.
Coffman TM; Carr DR; Yarger WE; Klotman PE
Transplantation; 1987 Feb; 43(2):282-5. PubMed ID: 3810836
[TBL] [Abstract][Full Text] [Related]
5. Acute effects of intravenous cyclosporine on blood pressure, renal hemodynamics, and urine prostaglandin production of healthy humans.
Weir MR; Klassen DK; Shen SY; Sullivan D; Buddemeyer EU; Handwerger BS
Transplantation; 1990 Jan; 49(1):41-7. PubMed ID: 2301025
[TBL] [Abstract][Full Text] [Related]
6. The role of eicosanoids in cyclosporine nephrotoxicity in the rat.
Erman A; Chen-Gal B; Rosenfeld J
Biochem Pharmacol; 1989 Jul; 38(13):2153-7. PubMed ID: 2735953
[TBL] [Abstract][Full Text] [Related]
7. Volume-induced natriuresis in healthy women: renal metabolism of prostacyclin and thromboxane, and physiological role of prostanoids.
Agnoli GC; Borgatti R; Cacciari M; Lenzi P; Marinelli M; Stipo L
Prostaglandins Leukot Essent Fatty Acids; 2001 Feb; 64(2):95-103. PubMed ID: 11237476
[TBL] [Abstract][Full Text] [Related]
8. Improvement of renal function with a selective thromboxane A2 synthetase inhibitor, DP-1904, in lupus nephritis.
Yoshida T; Kameda H; Ichikawa Y; Tojo T; Homma M
J Rheumatol; 1996 Oct; 23(10):1719-24. PubMed ID: 8895147
[TBL] [Abstract][Full Text] [Related]
9. Increased urinary excretion of thromboxane B2 and 2,3-dinor-TxB2 in cyclosporin A nephrotoxicity.
Benigni A; Chiabrando C; Piccinelli A; Perico N; Gavinelli M; Furci L; Patino O; Abbate M; Bertani T; Remuzzi G
Kidney Int; 1988 Aug; 34(2):164-74. PubMed ID: 3184595
[TBL] [Abstract][Full Text] [Related]
10. The relationship of urinary thromboxane excretion to cyclosporine nephrotoxicity.
Schnabel FR; Wait RB; Kahng KU
Transplantation; 1991 Mar; 51(3):686-9. PubMed ID: 2006526
[TBL] [Abstract][Full Text] [Related]
11. Pressure-dependent distal tubular action of atrial natriuretic peptide in healthy humans.
Eiskjaer H; Nielsen CB; Pedersen EB
J Hypertens; 1996 Jan; 14(1):99-106. PubMed ID: 12013501
[TBL] [Abstract][Full Text] [Related]
12. Cyclosporine-induced changes in glomerular filtration rate and urea excretion.
Laskow DA; Curtis JJ; Luke RG; Julian BA; Jones P; Deierhoi MH; Barber WH; Diethelm AG
Am J Med; 1990 May; 88(5):497-502. PubMed ID: 2337107
[TBL] [Abstract][Full Text] [Related]
13. Renal excretion of kallikrein and eicosanoids in patients with type 1 (insulin-dependent) diabetes mellitus. Relationship to glomerular and tubular function.
Harvey JN; Edmundson AW; Jaffa AA; Martin LL; Mayfield RK
Diabetologia; 1992 Sep; 35(9):857-62. PubMed ID: 1397781
[TBL] [Abstract][Full Text] [Related]
14. Effect of short-term cyclosporine administration in rats on renin-angiotensin and thromboxane A2: possible relevance to the reduction in glomerular filtration rate.
Perico N; Zoja C; Benigni A; Ghilardi F; Gualandris L; Remuzzi G
J Pharmacol Exp Ther; 1986 Oct; 239(1):229-35. PubMed ID: 3531461
[TBL] [Abstract][Full Text] [Related]
15. [Functional renal effects of cyclosporin. Physiopathological mechanisms].
Deray G; Martinez F; Cacoub P; Baumelou A; Jacobs C
Nephrologie; 1988; 9(2):73-5. PubMed ID: 3050579
[TBL] [Abstract][Full Text] [Related]
16. Cyclosporine and urinary prostaglandins.
Kho TL; Teule J; Leunissen KM; Heidendahl GA; Lijnen P; Amery A; van Hooff JP
Transplant Proc; 1988 Jun; 20(3 Suppl 3):650-3. PubMed ID: 3291301
[No Abstract] [Full Text] [Related]
17. Abnormal prostanoid metabolism in lupus nephritis and the effects of a thromboxane A2 synthetase inhibitor, DP-1904.
Yoshida T; Ichikawa Y; Tojo T; Homma M
Lupus; 1996 Apr; 5(2):129-38. PubMed ID: 8743126
[TBL] [Abstract][Full Text] [Related]
18. Effect of thromboxane synthetase inhibition and angiotensin converting enzyme inhibition on acute cyclosporin A nephrotoxicity.
Grieve EM; Hawksworth GM; Simpson JG; Whiting PH
Biochem Pharmacol; 1990 Nov; 40(10):2323-9. PubMed ID: 2244933
[TBL] [Abstract][Full Text] [Related]
19. Renal hemodynamics and urinary excretion of 6-keto-prostaglandin F1 alpha and thromboxane B2 in newly diagnosed type I diabetic patients.
Gambardella S; Andreani D; Cancelli A; Di Mario U; Cardamone I; Stirati G; Cinotti GA; Pugliese F
Diabetes; 1988 Aug; 37(8):1044-8. PubMed ID: 3391343
[TBL] [Abstract][Full Text] [Related]
20. The reversal of experimental cyclosporin A nephrotoxicity by thromboxane synthetase inhibition.
Grieve EM; Hawksworth GM; Simpson JG; Whiting PH
Biochem Pharmacol; 1993 Mar; 45(6):1351-4. PubMed ID: 8466554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
